We advocate for compounding pharmacies and facilities on a range of state and federal issues affecting patient access to compounded medications. We represent pharmacists and technicians in both traditional 503A compounding pharmacies and 503B outsourcing facilities, as well as prescribers, patients, educators, and suppliers. We’re 5,000 members strong and growing.
Meet the people who have volunteered to lead our state-by-state defense of pharmacy compounding.
STATEMENT OF ALLIANCE FOR PHARMACY COMPOUNDING CEO SCOTT BRUNNER, CAE, ON FDA’S ANNOUNCED INTENTION TO take decisive steps to restrict GLP-1 active ...
Several state legislatures have bills designed to unnecessarily burden and restrict lawful pharmacy compounding — we're fighting them all.
We formally asked the agency to reverse its decision classifying desiccated thyroid extract as a biological.
APC’s February CE webinar is all about our furry, scaly, and feathered friends.
.png?width=410&height=320&name=image-container%20(1).png)
.png?width=410&height=320&name=image-container%20(2).png)
.png?width=411&height=320&name=image-container%20(3).png)
.png?width=410&height=320&name=image-container%20(4).png)
.png)
.png?width=17&height=16&name=folder%20(1).png){kind=small}
%20Pharma-GS.png)
